Navigation Links
Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry
Date:6/26/2008

EWING, N.J., June 26 /PRNewswire/ -- Berkley Life Sciences, LLC, a member company of W. R. Berkley Corporation, today announced the introduction of LS Prime. LS Prime is a uniquely innovative primary liability policy designed to address the complex risks faced by life science companies of all sizes.

LS Prime features comprehensive, worldwide products liability, clinical trial, errors and omissions, and premises operations coverages. Included with this broad protection is an array of new features and enhancements not found in most existing life science policies:

-- Medical monitoring expense coverage even in the absence of physical injury;

-- Biological agents liability coverage including cleanup costs;

-- Coverage for materials and products in the care, custody or control of the insured;

-- Blanket clinical trial coverage including coverage for personal injury, abuse or molestation, and medical expenses;

-- Products withdrawal expense, including crisis management expenses;

-- Affirmed punitive damages coverage where allowed by law;

-- Blanket additional insured options to suit customer preferences;

-- Various tail coverage features that are optional, including:

-- Extended Coverage - extends coverage period and reporting

period

-- Batch Liability - batches losses to a particular policy period

-- E-BERP - extends reporting period without the traditional back-

end charge, and reduces some of the traditional reporting

requirements.

"LS Prime was developed to provide broad, seamless protection to life science enterprises," advised Jill Wadlund, President of Berkley Life Sciences. "The policy is comprehensive, yet scalable, so that customers purchase only the coverages they need. But LS Prime is just the beginning. We are committed to continuously listening to the needs of our customers. And we are equally committed to developing innovative, new insurance products and services to address those needs."

LS Prime will be issued in 48 states through Gemini Insurance Company, and in Rhode Island and Delaware through Nautilus Insurance Company. Both companies carry an A.M. Best Financial Strength Rating of A+ (Superior).

For additional information regarding Berkley Life Sciences or LS Prime Features & Benefits, visit http://www.berkleyls.com or contact Emily Urban, SVP, at 609.844.7800 or eurban@berkleyls.com.

About Berkley Life Sciences, LLC

Berkley Life Sciences, LLC, a member company of W. R. Berkley Corporation, is solely dedicated to serving the needs of the life science industry, providing sophisticated, innovative insurance products and services to life science customers of all sizes.

About W. R. Berkley Corporation

Founded in 1967, W. R. Berkley Corporation is an insurance holding company that is among the largest commercial lines writers in the United States and operates in five segments of the property casualty insurance business: specialty insurance, regional property casualty insurance, alternative markets, reinsurance and international.


'/>"/>
SOURCE Berkley Life Sciences, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Biosciences Announces New Leadership
2. SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
3. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
4. C3i Teams with Oracles Health Sciences Global Business Unit to Provide Customers with Clinical Training and Support Services
5. YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL
6. LI-COR(R) Biosciences Introduces New Tools for High Throughput Western Blotting
7. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
8. Derma Sciences MEDIHONEY(TM) Helps to Save Patients Limb
9. Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference
10. Scotland Showcased at BIO as Dynamic, Global Life Sciences Hub
11. Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Genprex, Inc. a biopharmaceutical company focused on ... announced that it has retained ICR Healthcare, a ... and advisory firm, to develop and implement an ... investor relations, public relations and digital communications to ... Genprex and its lead candidate Oncoprex, which is ...
(Date:12/7/2016)... Regen BioPharma Inc. (OTCQB: RGBPP) In a recent ... team of scientists in Guangzhou, China ... of NR2F6 in patients with early cervical cancer correlates with ... cancer tissue as well as in the normal tissue surrounding ... study and the first that I am aware of that ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
Breaking Biology News(10 mins):